• Mer. Nov 12th, 2025

cancer

  • Home
  • New Cleveland Clinic research finds up to 5% of Americans carry genetic mutations associated with cancer risk

New Cleveland Clinic research finds up to 5% of Americans carry genetic mutations associated with cancer risk

New Cleveland Clinic research reveals that up to 5% of Americans – approximately 17 million people – carry genetic mutations or “variants” linked to increased cancer susceptibility, regardless of risk…

The 2025 Nobel Prize in Physiology or Medicine to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi

The announcement of the Nobel Prize in Physiology or Medicine 2025. Photo: Cecilia Odlind The Nobel Assembly at Karolinska Institutet has decided to award the 2025 Nobel Prize in Physiology…

Could reducing inflammation help combat fatigue in people with early-stage breast cancer?

New research reveals that inflammatory responses may play a role in different types of fatigue experienced by many people with cancer. The findings are published by Wiley online in CANCER,…

Tumore al polmone a piccole cellule (ES-SCLC): FDA approva la combinazione lurbinectedina (Zepzelca®) e Atezolizumab (Tecentriq®) come terapia di mantenimento di prima linea

PharmaMar (MSE:PHM) ha annunciato che la Food and Drug Administration (FDA) statunitense ha concesso l’approvazione per Zepzelca® (lurbinectedina) in combinazione con atezolizumab (Tecentriq®) come trattamento di mantenimento per adulti con…

FDA approves PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-line Maintenance Therapy for Extensive-stage Small Cell Lung Cancer

harmaMar (MSE:PHM) has announced that the U.S Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin) in combination with atezolizumab (Tecentriq®) as a maintenance treatment for adults with…

The diamonds that could find cancer

University of Warwick researchers have built a new diamond-based magnetic field sensor that could be used to better find tumours through tracing magnetic fluid injected in the body. A cancer…

Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients

For some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes life-threatening side effects in those who carry certain genetic variants that can impact…

“AI platform” designs molecular missiles to attack cancer cells

Precision cancer treatment on a larger scale is moving closer after researchers have developed an AI platform that can tailor protein components and arm the patient’s immune cells to fight…

A new blood test may detect leukemia risk and replace bone marrow sampling

What if a blood test could reveal the pace of our aging – and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at…

Hereditary Mutations in BRCA Genes Increase Risk of Rare Lymphoma Among Women with Breast Cancer Who Received Textured Breast Implants

Women with breast cancer who were also carriers of the BRCA1 or BRCA2 mutation and received textured breast implants as part of their reconstructive surgery after mastectomy were 16 times…